Approval · Notice of Compliance 5985 · 2004
FLUCONAZOLE INJECTION: Notice of Compliance 5985
Issued December 8, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5985
- Date
- December 8, 2004
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antifungal
- Canadian reference product
- DIFLUCAN (Pfizer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUCONAZOLE INJECTION | 02261472 | Marketed |
Medicinal ingredients
- FLUCONAZOLE 2 MG per ML